AKT1 and cervical cancer: Mutations in PIK3CA affect glucose metabolism and proliferation in cervical cancer by activating the AKT/glycogen synthase kinase 3β/β-catenin signalling pathway [13], thereby reversing resistance to radiotherapy [14].